P. Robinan Gentry
ENVIRON International Corp.
602 East Georgia Avenue
Ruston
LA 71270
USA
Name/email consistency: high
- Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity. Gentry, P.R., McDonald, T.B., Sullivan, D.E., Shipp, A.M., Yager, J.W., Clewell, H.J. Environ. Mol. Mutagen. (2010)
- Comparison of tissue dosimetry in the mouse following chronic exposure to arsenic compounds. Gentry, P.R., Covington, T.R., Lawrence, G., McDonald, T., Snow, E.T., Germolec, D., Moser, G., Yager, J.W., Clewell, H.J. J. Toxicol. Environ. Health Part A (2005)
- Physiologically based pharmacokinetic modeling of arsenic in the mouse. Gentry, P.R., Covington, T.R., Mann, S., Shipp, A.M., Yager, J.W., Clewell, H.J. J. Toxicol. Environ. Health Part A (2004)
- Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Gentry, P.R., Covington, T.R., Clewell, H.J. Regul. Toxicol. Pharmacol. (2003)
- Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone. Gentry, P.R., Covington, T.R., Clewell, H.J., Anderson, M.E. J. Toxicol. Environ. Health Part A (2003)
- Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Gentry, P.R., Covington, T.R., Andersen, M.E., Clewell, H.J. Regul. Toxicol. Pharmacol. (2002)
- An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion. Gentry, P.R., Hack, C.E., Haber, L., Maier, A., Clewell, H.J. Toxicol. Sci. (2002)